Literature DB >> 11157779

Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival.

L Xing1, A M Venegas, A Chen, L Garrett-Beal, B F Boyce, H E Varmus, P L Schwartzberg.   

Abstract

Mutant src(-/-) mice have osteopetrosis resulting from defective osteoclasts, the cells that resorb bone. However, signaling pathways involving Src family members in osteoclasts remain unclear. We demonstrate that expression of a truncated Src molecule, Src251, lacking the kinase domain, induces osteopetrosis in wild-type and src(+/-) mice and worsens osteopetrosis in src(-/-) mice by a novel mechanism, increased osteoclast apoptosis. Induction of apoptosis by Src251 requires a functional SH2, but not an SH3, domain and is associated with reduced AKT kinase activity. Expression of Src251 dramatically reduces osteoclast survival in response to RANKL/TRANCE/OPGL, providing evidence that Src family kinases are required in vivo for survival signaling pathways downstream from TNF family receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157779      PMCID: PMC312612          DOI: 10.1101/gad.840301

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 2.  Cell biology of the osteoclast.

Authors:  G D Roodman
Journal:  Exp Hematol       Date:  1999-08       Impact factor: 3.084

3.  Three-dimensional structure of the tyrosine kinase c-Src.

Authors:  W Xu; S C Harrison; M J Eck
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.

Authors:  D D Schlaepfer; K C Jones; T Hunter
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.

Authors:  M A Lomaga; W C Yeh; I Sarosi; G S Duncan; C Furlonger; A Ho; S Morony; C Capparelli; G Van; S Kaufman; A van der Heiden; A Itie; A Wakeham; W Khoo; T Sasaki; Z Cao; J M Penninger; C J Paige; D L Lacey; C R Dunstan; W J Boyle; D V Goeddel; T W Mak
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

Review 6.  TRANCE is a TNF family member that regulates dendritic cell and osteoclast function.

Authors:  B R Wong; R Josien; Y Choi
Journal:  J Leukoc Biol       Date:  1999-06       Impact factor: 4.962

7.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

8.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

9.  The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Authors:  B R Wong; R Josien; S Y Lee; M Vologodskaia; R M Steinman; Y Choi
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

Authors:  K Fuller; B Wong; S Fox; Y Choi; T J Chambers
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

View more
  27 in total

1.  Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.

Authors:  Hiroyuki Kaneki; Ruolin Guo; Di Chen; Zhenqiang Yao; Edward M Schwarz; Ying E Zhang; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

2.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

Review 3.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

Review 4.  Mechanisms of tooth eruption and orthodontic tooth movement.

Authors:  G E Wise; G J King
Journal:  J Dent Res       Date:  2008-05       Impact factor: 6.116

5.  Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data.

Authors:  Brendan Boyce; Lianping Xing
Journal:  Clin Investig (Lond)       Date:  2011-12-01

6.  Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.

Authors:  Weiqin Chen; Donald B Jump; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

7.  c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.

Authors:  John C Edwards; Christopher Cohen; Weibing Xu; Paul H Schlesinger
Journal:  J Biol Chem       Date:  2006-07-10       Impact factor: 5.157

8.  c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.

Authors:  Takashi Izawa; Wei Zou; Jean C Chappel; Jason W Ashley; Xu Feng; Steven L Teitelbaum
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

9.  The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts.

Authors:  Olivier Destaing; Archana Sanjay; Cecile Itzstein; William C Horne; Derek Toomre; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

10.  TRAF2-MLK3 interaction is essential for TNF-alpha-induced MLK3 activation.

Authors:  Gautam Sondarva; Chanakya N Kundu; Suneet Mehrotra; Rajakishore Mishra; Velusamy Rangasamy; Pradeep Sathyanarayana; Rajarshi S Ray; Basabi Rana; Ajay Rana
Journal:  Cell Res       Date:  2009-11-17       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.